share_log

bluebird bio | 144: Notice of proposed sale of securities pursuant to Rule 144

bluebird bio | 144: Notice of proposed sale of securities pursuant to Rule 144

bluebird bio | 144:拟议出售证券
美股SEC公告 ·  2024/10/01 10:36

Moomoo AI 已提取核心信息

Thomas J Klima, an officer at Bluebird Bio, Inc., is set to sell 1,006 common shares of the company on 09/30/2024, as per the latest filing. The shares to be sold were part of a larger acquisition of 2,750 shares on 09/01/2022, which were obtained as restricted stock units that vested and are being sold due to withholding taxes. The transaction is part of a pre-planned trading arrangement set on 05/10/2023. No other sales have been reported in the past three months.
Thomas J Klima, an officer at Bluebird Bio, Inc., is set to sell 1,006 common shares of the company on 09/30/2024, as per the latest filing. The shares to be sold were part of a larger acquisition of 2,750 shares on 09/01/2022, which were obtained as restricted stock units that vested and are being sold due to withholding taxes. The transaction is part of a pre-planned trading arrangement set on 05/10/2023. No other sales have been reported in the past three months.
Bluebird Bio, Inc.的官员Thomas J Klima计划于2024年09月30日卖出公司的1,006股普通股,根据最新提交的文件。待售股票是作为2022年09月01日更大规模收购的2,750股的一部分,这些股票是作为受限制的股票单位获取的,现已解锁并出售,以支付代扣税款。该交易是根据在2023年05月10日制定的预先计划的交易安排进行的。过去三个月未报告任何其他销售。
Bluebird Bio, Inc.的官员Thomas J Klima计划于2024年09月30日卖出公司的1,006股普通股,根据最新提交的文件。待售股票是作为2022年09月01日更大规模收购的2,750股的一部分,这些股票是作为受限制的股票单位获取的,现已解锁并出售,以支付代扣税款。该交易是根据在2023年05月10日制定的预先计划的交易安排进行的。过去三个月未报告任何其他销售。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息